EP2301967 - Single domain antibodies for nasal administration [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.06.2012 Database last updated on 02.09.2024 | Most recent event Tooltip | 08.06.2012 | Application deemed to be withdrawn | published on 11.07.2012 [2012/28] | Applicant(s) | For all designated states Ablynx N.V. Technologiepark 21 9052 Ghent-Zwijnaarde / BE | [2011/42] |
Former [2011/13] | For all designated states Ablynx N.V. Technologiepark 4 9052 Zwijnaarde / BE | Inventor(s) | 01 /
Silence, Karen Jean Tombeurstraat 21 B-3090, Overijse / BE | 02 /
Vaeck, Mark Nieuwstraat 37 B-1981, Hofstade / BE | 03 /
Van Bergen en Henegouwen, Paul P.M.P. Louis Bouwmeesterlaan 127 NL-3584, GE Utrecht / NL | [2011/13] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
Former [2011/13] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE | Application number, filing date | 10178270.4 | 07.11.2003 | [2011/13] | Priority number, date | US20020425073P | 08.11.2002 Original published format: US 425073 P | US20020425063P | 08.11.2002 Original published format: US 425063 P | EP20030447005 | 10.01.2003 Original published format: EP 03447005 | WO2003EP06581 | 23.06.2003 Original published format: PCT/EP0306/581 | WO2003EP07313 | 08.07.2003 Original published format: PCT/EP0307/313 | [2011/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2301967 | Date: | 30.03.2011 | Language: | EN | [2011/13] | Type: | A3 Search report | No.: | EP2301967 | Date: | 13.07.2011 | [2011/28] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.06.2011 | Classification | IPC: | C07K16/42, C07K16/24, C07K16/30, C07K16/12, C07K16/10, C07K16/40, C07K16/28, C12N15/13, A61K39/395, A61P11/06, A61P35/00, A61P31/06, A61P31/16 | [2011/28] | CPC: |
C07K16/2863 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/14 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/00 (EP);
A61P13/12 (EP);
A61P15/08 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/06 (EP);
A61P31/16 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/06 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
C07K16/18 (EP,US);
C07K16/241 (EP,RU,US);
C07K16/249 (EP,US);
C07K16/2875 (EP,US);
C07K16/36 (EP,US);
C07K16/40 (EP,US);
C07K16/4291 (EP,US);
C07K16/468 (RU);
A61K2039/505 (EP,US);
C07K2317/22 (EP,US);
C07K2317/24 (EP,US);
C07K2317/31 (EP,US);
C07K2317/565 (EP,US);
C07K2317/569 (EP,US);
C07K2317/62 (EP,US);
C07K2317/626 (EP,US);
C07K2317/76 (EP,US);
|
Former IPC [2011/13] | C07K16/18, A61K39/395, A61P29/00, A61P35/00, A61P37/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2011/13] | Extension states | AL | 22.09.2010 | LT | 22.09.2010 | LV | 22.09.2010 | MK | 22.09.2010 | Title | German: | Einzeldomänenantikörper zur nasalen Verabreichung | [2011/13] | English: | Single domain antibodies for nasal administration | [2011/13] | French: | Anticorps à domaine unique pour administration nasale | [2011/13] | Examination procedure | 22.09.2010 | Examination requested [2011/13] | 14.01.2012 | Application deemed to be withdrawn, date of legal effect [2012/28] | 21.02.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/28] | Parent application(s) Tooltip | EP03775004.9 / EP1558650 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030775004) is 06.07.2006 | Fees paid | Renewal fee | 22.09.2010 | Renewal fee patent year 03 | 22.09.2010 | Renewal fee patent year 04 | 22.09.2010 | Renewal fee patent year 05 | 22.09.2010 | Renewal fee patent year 06 | 22.09.2010 | Renewal fee patent year 07 | 22.09.2010 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.11.2011 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]WO9710846 (INTRACEL CORP [US], et al) [X] 1-4,6 * page 14, line 11 - page 15, line 10 * [Y] 5,12,13 [I] 7-11,14,15; | [Y]WO02080967 (NAT JEWISH MED & RES CENTER [US]) [Y] 5 * page 7, line 1; example 1; claim 25 *; | [Y]WO9104054 (MILLAR ANN BRIGID [GB]) [Y] 8,9 * abstract * * claims 1,5 *; | [Y]WO9102078 (PEPTIDE TECHNOLOGY LTD [AU]) [Y] 8,9 * page 4, lines 15-24 *; | [A]WO02081649 (UNIV PENNSYLVANIA [US], et al) [A] 10,11 * claim 31 *; | [AP]WO03002609 (MEDICAL RES COUNCIL [GB], et al) [AP] 1-15 * page 47, line 26 * | [Y] - "OMALIZUMAB - ANTI-IGE MONOCLONAL ANTIBODY E25, E25, HUMANISED ANTI-IGE MAB, IGE 025, MONOCLONAL ANTIBODY E25, OLIZUMAB, XOLAIR, RHUMAB-E25", BIODRUGS: CLINICAL IMMUNOTHERAPEUTICS, BIOPHARMACEUTICALS AND GENE THERAPY, ADIS INTERNATIONAL, FR, (20020101), vol. 16, no. 5, doi:10.2165/00063030-200216050-00009, ISSN 1173-8804, pages 380 - 386, XP009076298 [Y] 12,13 * abstract * DOI: http://dx.doi.org/10.2165/00063030-200216050-00009 | [A] - MUYLDERMANS S, "SINGLE DOMAIN CAMEL ANTIBODIES: CURRENT STATUS", REVIEWS IN MOLECULAR BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, NL, (200106), vol. 74, no. 4, ISSN 1389-0352, pages 277 - 302, XP001057480 [A] 1-15 * table 1 * DOI: http://dx.doi.org/10.1016/S1389-0352(01)00021-6 | by applicant | US4714759 | US4962035 | US4940782 | US4946788 | US5091313 | US5252467 | US5231026 | WO9304173 | US5428133 | US5422258 | EP0841946 | WO9404678 | WO9749805 | WO03035694 | EP0294703 | WO9634103 | EP0707473 | EP0684814 | US5629001 | US6514496 | US6267958 | US6190662 | WO0023471 | US6361938 | US5399346 | US4608392 | US4992478 | US4559157 | US4820508 | US4938949 | WO03054016 | - BANIYASH; ESHHAR, EUROPEAN JOURNAL OF IMMUNOLOGY, (1984), vol. 14, pages 799 - 807 | - RUP; KAHN, INTERNATIONAL ARCHIVES ALLERGY AND APPLIED IMMUNOLOGY, (1989), vol. 89, pages 387 - 393 | - BANIYASH ET AL., MOLECULAR IMMUNOLOGY, (1988), vol. 25, pages 705 - 711 | - HOOK ET AL., FEDERATION PROCEEDINGS, vol. 40, no. 3 | - PRESTA ET AL., J. IMMUNOL., (1993), vol. 151, pages 2623 - 2832 | - BLATTLER, BIOCHEMISTRY, vol. 24, pages 1517 - 1524 | - SAMBROOK ET AL., Molecular Cloning, Laboratory Manuel, COLD SPRING, HARBOR LABORATORY PRESS | - MUYLDERMANS, S., REVIEWS IN MOLECULAR BIOTECHNOLOGY, (2001), vol. 74, pages 277 - 303 | - PARTRIDGE, ADV. DRUG DELIVERY REVIEWS, (1995), vol. 15, pages 5 - 36 | - POUL MA ET AL., J MOL BIOL, (2000), vol. 301, pages 1149 - 1161 | - CARMAN, C.V.; BENOVIC, J.L., CURRENT OPINION IN NEUROBIOLOGY, (1998), vol. 8, pages 335 - 344 | - KASSNER, BIOCHEM BIOPHYS RES COMMUN, (1999), vol. 264, pages 921 - 928 | - LAROCCA D ET AL., CURR. PHARM. BIOTECHNOL, (2002), vol. 3, pages 45 - 57 | - MUYIDERMANS, S., REVIEWS IN MOLECULAR BIOTECHNOLOGY, (2001), vol. 74, pages 277 - 303 | - MARTIN, E.W., Remington's Pharmaceutical Sciences, ed. 4, MACK PUBLISHING CO. | - MAGNI ET AL., ANAL BIOCHEM, (2001), vol. 298, pages 181 - 188 | - J. BIOI. CHEM., (1921), vol. 49, page 183 | - OKAYASU ET AL., GASTROENTEROLOGY, (1990), vol. 98, pages 694 - 702 | - G. KOJOUHAROFF, CLIN. EXP. IMMUNOL., (1997), vol. 107, pages 353 - 8 | - G. KOJOUHAROFF ET AL., CIIN. EXP. IMMUNOL., (1997), vol. 107, pages 353 - 8 | - COHEN S; USHIRO H; STOSCHECK C; CHINKERS M, "A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles", J. BIOL. CHEM., (1982), vol. 257, pages 1523 - 31 | - CHOMCZYNSKI P; SACCHí N, "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction", ANAL BIOCHEM, (1987), vol. 162, pages 156 - 159 | - DE HAARD HJ; VAN NEER N; REURS A; HUFTON SE; ROOVERS RC; HENDERIKX P; DE BRUINE AP; ARENDS JW; HOOGENBOOM HR, "A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies", J. BIOI. CHEM., (1999), vol. 274, pages 18218 - 30 | - DEFIZE LH; MOOLENAAR WH; VAN DER SAAG PT; DE LAAT SW, "Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies", EMBO J., (1986), vol. 5, pages 1187 - 92 | - SATO JD; KAWAMOTO T; LE AD; MENDELSOHN J; POLIKOFF J; SATO GH, "Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors", MOL. BIO!. MED., (1983), vol. 1, pages 511 - 529 | - POUL MA; BECERRIL B; NIELSEN UB; MORISSON P; MARKS JD, "Selection of tumor-specific internalizing human antibodies from phage libraries", J. MOL, BIOL., (2000), vol. 301, pages 1149 - 61 | - POUL MA, J MOL BIOL, (1999), vol. 288, pages 203 - 211 | - LAROCCO, MOLECULAR THERAPY, (2001), vol. 3, pages 476 - 484 | - POUL MA ET AL., J MOL BIOL, (1999), vol. 288, pages 203 - 211 | - CONRATH ET AL., J BIOI CHEM, (2001), vol. 276, pages 7346 - 7350 | - OKAYASU 1; HATAKEYAMA S; YAMADA M; OHKUSA T; INAGAKI Y; NAKAYA R, "A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice", GASTROENTEROLOGY, (1990), vol. 98, pages 694 - 702 | - KOJOUHAROFF G; HANS W; OBERMEIER F; MANNEL DN; ANDUS T; SCHOLMERICH J; GROSS V; FALK W, "Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice", CLIN EXP IMMUNOL, (1997), vol. 107, pages 353 - 8 | - SALMELA MT; PENDER SL; REUNALA T; MACDONALD T; SAARIALHO-KERE U., GUT, (2001), vol. 48, no. 4, pages 496 - 502 | - CHAVEY C; MARI B; MONTHOUEL MN; BONNAFOUS S; ANGLARD P; VAN OBBERGHEN E; TARTARE-DECKERT S., J. BIOL. CHEM., (2003), vol. 278, pages 11888 - 11896 | - CHURG A; WANG RD; TAI H; WANG X; XIE C; DAI J; SHAPIRO SD; WRIGHT JL, AM. J. RESPIR. CRIT. CARE MED., (2003), vol. 167, pages 1083 - 1089 | - R LANG; A KOCOUREK; M BRAUN; H TSCHESCHE; R HUBER; W BODE; K MASKOS, J MOL BIOL, (200109), vol. 312, no. 4, pages 731 - 42 | - YOSHIKATSU KANEKO; MINORU SAKATSUME; YUANSHENG XIE; TAKESHI KURODA; MICHIKO LGASHIMA; ICHIEI NARITA; FUMITAKE GEJYO, THE JOURNAL OF IMMUNOLOGY, (2003), vol. 170, pages 3377 - 3385 | - DING Y; SHIMADA Y; GORRIN-RIVAS MJ; ITAMI A; LI Z; HONG T; MAEDA M; KOMOTO I; KAWABE A; KAGANOI J, ONCOLOGY, (2002), vol. 63, no. 4, pages 378 - 84 | - KERKELA E; ALA-AHO R; JESKANEN L; RECHARDT 0; GRENMAN R; SHAPIRO SD; KAHARI VM; SAARIALHO-KERE U, J INVEST DERMATOL, (200006), vol. 114, no. 6, pages 1113 - 9 |